80 research outputs found

    Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common use of anthracycline-base chemotherapy and on North American populations with a mean BMI classified as overweight. Our study was aimed to evaluate the prognostic value of weight change during anthracycline-based chemotherapy on non metastatic breast cancer (European population) with a long term follow-up.</p> <p>Methods</p> <p>Patients included 111 women diagnosed with early stage breast cancer and locally advanced breast cancer who have been treated by anthracycline-based chemotherapy regimen between 1976 and 1989. The relative percent weight variation (WV) between baseline and postchemotherapy treatment was calculated and categorized into either weight change (WV > 5%) or stable (WV < 5%). The median follow-up was 20.4 years [19.4 - 27.6]. Cox proportional hazard models were used to evaluate any potential association of weight change and known prognostic factors with the time to recurrence and overall survival.</p> <p>Results</p> <p>Baseline BMI was 24.4 kg/m2 [17.1 - 40.5]. During chemotherapy treatment, 31% of patients presented a notable weight variation which was greater than 5% of their initial weight.</p> <p>In multivariate analyses, weight change (> 5%) was positively associated with an increased risk of both recurrence (RR 2.28; 95% CI: 1.29-4.03) and death (RR 2.11; 95% CI: 1.21-3.66).</p> <p>Conclusions</p> <p>Our results suggest that weight change during breast-cancer chemotherapy treatment may be related to poorer prognosis with higher reccurence and higher mortality in comparison to women who maintained their weight.</p

    A powerful traversal language for discoverable graphs

    No full text
    There is renewed interest in graph query languages, where querying Web data (such as linked data, or on-line social networks) is considered an important application scenario. Implementing responsive evaluation techniques for queries on Web graphs (where navigation causes additional data to be discovered on the fly) demands a judicious choice of language features that achieve high expressibility while retaining low complexity. This paper presents GenTLE, a graph traversal language that targets Web data and offers a novel and attractive expressiveness/ complexity trade-off. GenTLE expressions are evaluated on discoverable graphs. The proposed language retains the low polynomial time (data and query) combined complexity of Nested Regular Expression languages while significantly extending their expressibility with support for path conjunction, path negation, and the output of explanation subgraphs as answers
    • …
    corecore